SC

Srinivas Chiluveru

Director Director DIN 03013706
DIN 03013706 First appointment Apr 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Srinivas Chiluveru

Data last updated:

Srinivas Chiluveru was a Director at Chemveda Life Sciences India Private Limited (2012–2014) and Director at Namitha Hospitals Private Limited (from 2010). The companies operate in Pharma.

DIN 03013706
Primary Designation Director
Industry Pharma
First Appointment 15 Apr 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Dec 20122008₹116 Cr (FY 2024)Active
Namitha Hospitals Private Limited U85110TG2010PTC067958
Director15 Apr 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Namitha Hospitals Private Limited
Chemveda Life Sciences India Private Limited
Premium access

Shareholding and investment profile for Srinivas Chiluveru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivas Chiluveru

Srinivas Chiluveru was first appointed on 15 Apr 2010 as Director at Namitha Hospitals Private Limited. The most recent appointment on record is 03 Dec 2012 at Chemveda Life Sciences India Private Limited.

Srinivas Chiluveru held 2 earlier board appointments: Chemveda Life Sciences India Private Limited (Director, 03 Dec 2012 to 30 Nov 2014); Namitha Hospitals Private Limited (Director, from 15 Apr 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available